These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33764785)

  • 1. Crystal Structure and Subsequent Ligand Design of a Nonriboside Partial Agonist Bound to the Adenosine A
    Amelia T; van Veldhoven JPD; Falsini M; Liu R; Heitman LH; van Westen GJP; Segala E; Verdon G; Cheng RKY; Cooke RM; van der Es D; IJzerman AP
    J Med Chem; 2021 Apr; 64(7):3827-3842. PubMed ID: 33764785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation.
    Lebon G; Warne T; Edwards PC; Bennett K; Langmead CJ; Leslie AG; Tate CG
    Nature; 2011 May; 474(7352):521-5. PubMed ID: 21593763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of molecular modeling of agonist binding in light of the crystallographic structure of an agonist-bound A₂A adenosine receptor.
    Deflorian F; Kumar TS; Phan K; Gao ZG; Xu F; Wu H; Katritch V; Stevens RC; Jacobson KA
    J Med Chem; 2012 Jan; 55(1):538-52. PubMed ID: 22104008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular docking screening using agonist-bound GPCR structures: probing the A2A adenosine receptor.
    Rodríguez D; Gao ZG; Moss SM; Jacobson KA; Carlsson J
    J Chem Inf Model; 2015 Mar; 55(3):550-63. PubMed ID: 25625646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel thiazolo[5,4-d]pyrimidine derivatives as human A
    Varano F; Catarzi D; Falsini M; Vincenzi F; Pasquini S; Varani K; Colotta V
    Bioorg Med Chem; 2018 Jul; 26(12):3688-3695. PubMed ID: 29880250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of a Na
    Noël F; do Monte FM
    J Pharmacol Toxicol Methods; 2017; 84():51-56. PubMed ID: 27810394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of an agonist-bound human A2A adenosine receptor.
    Xu F; Wu H; Katritch V; Han GW; Jacobson KA; Gao ZG; Cherezov V; Stevens RC
    Science; 2011 Apr; 332(6027):322-7. PubMed ID: 21393508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Could the presence of sodium ion influence the accuracy and precision of the ligand-posing in the human A
    Margiotta E; Deganutti G; Moro S
    J Comput Aided Mol Des; 2018 Dec; 32(12):1337-1346. PubMed ID: 30361971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and pharmacological profile of a novel covalent partial agonist for the adenosine A
    Yang X; Dilweg MA; Osemwengie D; Burggraaff L; van der Es D; Heitman LH; IJzerman AP
    Biochem Pharmacol; 2020 Oct; 180():114144. PubMed ID: 32653590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A
    Eddy MT; Martin BT; Wüthrich K
    Structure; 2021 Feb; 29(2):170-176.e3. PubMed ID: 33238145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statistics for the analysis of molecular dynamics simulations: providing P values for agonist-dependent GPCR activation.
    Bruzzese A; Dalton JAR; Giraldo J
    Sci Rep; 2020 Nov; 10(1):19942. PubMed ID: 33203907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor.
    Preti D; Baraldi PG; Saponaro G; Romagnoli R; Aghazadeh Tabrizi M; Baraldi S; Cosconati S; Bruno A; Novellino E; Vincenzi F; Ravani A; Borea PA; Varani K
    J Med Chem; 2015 Apr; 58(7):3253-67. PubMed ID: 25780876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-Activity Relationships of the Sustained Effects of Adenosine A2A Receptor Agonists Driven by Slow Dissociation Kinetics.
    Hothersall JD; Guo D; Sarda S; Sheppard RJ; Chen H; Keur W; Waring MJ; IJzerman AP; Hill SJ; Dale IL; Rawlins PB
    Mol Pharmacol; 2017 Jan; 91(1):25-38. PubMed ID: 27803241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology and structure of isolated conformations of the adenosine A₂A receptor define ligand efficacy.
    Bennett KA; Tehan B; Lebon G; Tate CG; Weir M; Marshall FH; Langmead CJ
    Mol Pharmacol; 2013 May; 83(5):949-58. PubMed ID: 23429888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simulation and Comparative Analysis of Different Binding Modes of Non-nucleoside Agonists at the A2A Adenosine Receptor.
    Dal Ben D; Buccioni M; Lambertucci C; Marucci G; Santinelli C; Spinaci A; Thomas A; Volpini R
    Mol Inform; 2016 Sep; 35(8-9):403-13. PubMed ID: 27546044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BAY60-6583 acts as a partial agonist at adenosine A2B receptors.
    Hinz S; Lacher SK; Seibt BF; Müller CE
    J Pharmacol Exp Ther; 2014 Jun; 349(3):427-36. PubMed ID: 24633424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allosteric interactions between agonists and antagonists within the adenosine A2A receptor-dopamine D2 receptor heterotetramer.
    Bonaventura J; Navarro G; Casadó-Anguera V; Azdad K; Rea W; Moreno E; Brugarolas M; Mallol J; Canela EI; Lluís C; Cortés A; Volkow ND; Schiffmann SN; Ferré S; Casadó V
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):E3609-18. PubMed ID: 26100888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the A2A adenosine G-protein-coupled receptor by conformational selection.
    Ye L; Van Eps N; Zimmer M; Ernst OP; Prosser RS
    Nature; 2016 May; 533(7602):265-8. PubMed ID: 27144352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, Synthesis, and Pharmacological Characterization of 2-(2-Furanyl)thiazolo[5,4-d]pyrimidine-5,7-diamine Derivatives: New Highly Potent A
    Varano F; Catarzi D; Vincenzi F; Betti M; Falsini M; Ravani A; Borea PA; Colotta V; Varani K
    J Med Chem; 2016 Dec; 59(23):10564-10576. PubMed ID: 27933962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and energetic effects of A2A adenosine receptor mutations on agonist and antagonist binding.
    Keränen H; Gutiérrez-de-Terán H; Åqvist J
    PLoS One; 2014; 9(10):e108492. PubMed ID: 25285959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.